Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Heart Failure

  Free Subscription


05.07.2021

4 Am J Cardiol
1 Ann Thorac Surg
1 BMJ
3 Circ Heart Fail
2 Clin Cardiol
3 Eur Heart J
10 Eur J Heart Fail
2 Heart
2 Int J Cardiol
4 J Am Coll Cardiol
2 J Card Fail
1 J Cardiovasc Pharmacol
2 J Thorac Cardiovasc Surg
1 PLoS Med
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Cardiol

  1. ROWIN EJ, Maron BJ, Wells S, Burrows A, et al
    Usefulness of Global Longitudinal Strain to Predict Heart Failure Progression in Patients With Nonobstructive Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2021;151:86-92.
    PubMed         Abstract available

  2. GREWAL D, Partow-Navid R, Garcia D, Coney J, et al
    Role of Guideline Directed Medical Therapy Doses and Optimization in Patients Hospitalized With Decompensated Systolic Heart Failure.
    Am J Cardiol. 2021;151:64-69.
    PubMed         Abstract available

  3. SHAH M, Rodriguez CJ, Bartz TM, Lyles MF, et al
    Incidence, Determinants and Mortality of Heart Failure Associated With Medical-Surgical Procedures in Patients >/= 65 Years of Age (from the Cardiovascular Health Study).
    Am J Cardiol. 2021 Jun 23. pii: S0002-9149(21)00491.
    PubMed         Abstract available

  4. KELLY KL, Wentz RJ, Johnson BD, Miller WL, et al
    Relation of Intravascular Volume Profiles to Heart Failure Progression and Clinical Outcomes.
    Am J Cardiol. 2021 Jun 29. pii: S0002-9149(21)00494.
    PubMed         Abstract available


    Ann Thorac Surg

  5. ROSENBAUM AN, Ternus BW, Pahwa S, Stulak JM, et al
    Risk of Liver Dysfunction After Left Ventricular Assist Device Implantation.
    Ann Thorac Surg. 2021;111:1961-1967.
    PubMed         Abstract available


    BMJ

  6. BARTKO PE, Heitzinger G, Pavo N, Heitzinger M, et al
    Burden, treatment use, and outcome of secondary mitral regurgitation across the spectrum of heart failure: observational cohort study.
    BMJ. 2021;373:n1421.
    PubMed         Abstract available


    Circ Heart Fail

  7. ABDEL-QADIR H, Tai F, Croxford R, Austin PC, et al
    Characteristics and Outcomes of Women Developing Heart Failure After Early Stage Breast Cancer Chemotherapy: A Population-Based Matched Cohort Study.
    Circ Heart Fail. 2021 Jun 30:CIRCHEARTFAILURE120008110.
    PubMed         Abstract available

  8. CALO L, Bianchi V, Ferraioli D, Santini L, et al
    Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management: An Analysis in Clinical Practice.
    Circ Heart Fail. 2021 Jun 30:CIRCHEARTFAILURE120008134.
    PubMed         Abstract available

  9. LOGANTHA SJRJ, Cai XJ, Yanni J, Jones CB, et al
    Remodeling of the Purkinje Network in Congestive Heart Failure in the Rabbit.
    Circ Heart Fail. 2021 Jun 30:CIRCHEARTFAILURE120007505.
    PubMed         Abstract available


    Clin Cardiol

  10. HOSEINI SG, Heshmat-Ghahdarijani K, Khosrawi S, Garakyaraghi M, et al
    Effect of melatonin supplementation on endothelial function in heart failure with reduced ejection fraction: A randomized, double-blinded clinical trial.
    Clin Cardiol. 2021 Jun 28. doi: 10.1002/clc.23682.
    PubMed         Abstract available

  11. BEAUVAIS F, Tartiere L, Pezel T, Motet C, et al
    First symptoms and health care pathways in hospitalized patients with acute heart failure: ICPS2 survey. A report from the Heart Failure Working Group (GICC) of the French Society of Cardiology.
    Clin Cardiol. 2021 Jun 26. doi: 10.1002/clc.23666.
    PubMed         Abstract available


    Eur Heart J

  12. DIDERIKSEN JR, Christiansen MK, Johansen JB, Nielsen JC, et al
    Long-term outcomes in young patients with atrioventricular block of unknown aetiology.
    Eur Heart J. 2021 Feb 18. pii: 6143533. doi: 10.1093.
    PubMed         Abstract available

  13. LAM CSP, Ferreira JP, Pfarr E, Sim D, et al
    Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial.
    Eur Heart J. 2021 Jun 29. pii: 6310468. doi: 10.1093.
    PubMed         Abstract available

  14. ONO M, Garg S, Onuma Y, Serruys PW, et al
    Coronary artery bypass grafting versus percutaneous coronary intervention in ischaemic heart failure. Can reliable treatment decisions in high-risk patients be based on non-randomized data?
    Eur Heart J. 2021 Jul 1. pii: 6311994. doi: 10.1093.
    PubMed        


    Eur J Heart Fail

  15. MCEWAN P, Ponikowski P, Davis JA, Rosano G, et al
    Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost-effectiveness analysis utilising AFFIRM-AHF.
    Eur J Heart Fail. 2021 Jun 30. doi: 10.1002/ejhf.2270.
    PubMed         Abstract available

  16. YAFASOVA A, Butt JH, Rorth R
    Troponin - An important prognostic biomarker in patients with heart failure and reduced ejection fraction?
    Eur J Heart Fail. 2021 Jun 29. doi: 10.1002/ejhf.2282.
    PubMed        

  17. GREENE SJ, Fonarow GC
    Clinical Inertia and Medical Therapy for Heart Failure: The Unintended Harms of "First, Do No Harm".
    Eur J Heart Fail. 2021 Jun 29. doi: 10.1002/ejhf.2283.
    PubMed        

  18. SAVARESE G, Bodegard J, Norhammar A, Sartipy P, et al
    Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden).
    Eur J Heart Fail. 2021 Jun 15. doi: 10.1002/ejhf.2271.
    PubMed         Abstract available

  19. TOMASONI D, Adamo M, Metra M
    May 2021 at a glance: focus on acute heart failure and heart failure with preserved ejection fraction.
    Eur J Heart Fail. 2021;23:691-692.
    PubMed        

  20. ABDIN A, Bohm M
    Renal function and vericiguat in heart failure patients: Light at the end of the tunnel!
    Eur J Heart Fail. 2021 Jun 26. doi: 10.1002/ejhf.2280.
    PubMed        

  21. KHAN MS, Khan F, Fonarow GC, Sreenivasan J, et al
    Dietary Interventions and Nutritional Supplements for Heart Failure: A Systematic Appraisal and Evidence Map.
    Eur J Heart Fail. 2021 Jun 26. doi: 10.1002/ejhf.2278.
    PubMed         Abstract available

  22. ANKER SD, Khan MS, Shahid I, Filippatos G, et al
    SGLT-2 Inhibitors in Heart Failure with Preserved Ejection Fraction Reasons for Optimism.
    Eur J Heart Fail. 2021 Jun 26. doi: 10.1002/ejhf.2279.
    PubMed        

  23. PONIKOWSKI P, Alemayehu W, Oto A, Bahit MC, et al
    Vericiguat in Patients with Atrial Fibrillation and Heart Failure with Reduced Ejection Fraction: Insights from the VICTORIA trial.
    Eur J Heart Fail. 2021 Jun 30. doi: 10.1002/ejhf.2285.
    PubMed         Abstract available

  24. SHAH SJ, Cowie MR, Wachter R, Szecsody P, et al
    Baseline Characteristics of Patients in the PARALLAX Trial: Insights into Quality of Life and Exercise Capacity in Heart Failure with Preserved Ejection Fraction.
    Eur J Heart Fail. 2021 Jun 25. doi: 10.1002/ejhf.2277.
    PubMed         Abstract available


    Heart

  25. TAYLOR CJ, Lay-Flurrie SL, Ordonez-Mena JM, Goyder CR, et al
    Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004-2018.
    Heart. 2021 Jun 28. pii: heartjnl-2021-319196. doi: 10.1136/heartjnl-2021-319196
    PubMed         Abstract available

  26. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    PubMed         Abstract available


    Int J Cardiol

  27. ISHIWATA S, Matsue Y, Nakamura Y, Dotare T, et al
    Clinical and prognostic values of urinary alpha1-microglobulin as a tubular marker in acute heart failure.
    Int J Cardiol. 2021 Jun 26. pii: S0167-5273(21)01079.
    PubMed         Abstract available

  28. DE LA ESPRIELLA R, Minana G, Santas E, Nunez G, et al
    Effects of empagliflozin on CA125 trajectory in patients with chronic congestive heart failure.
    Int J Cardiol. 2021 Jun 30. pii: S0167-5273(21)01084.
    PubMed         Abstract available


    J Am Coll Cardiol

  29. LAM CSP, Solomon SD
    Classification of Heart Failure According to Ejection Fraction: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;77:3217-3225.
    PubMed         Abstract available

  30. YU B, Roberts MB, Raffield LM, Zekavat SM, et al
    Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
    J Am Coll Cardiol. 2021;78:42-52.
    PubMed         Abstract available

  31. FUSTER JJ
    Clonal Hematopoiesis and Incident Heart Failure Risk: The Clone Wars Reach the Myocardium.
    J Am Coll Cardiol. 2021;78:53-55.
    PubMed        

  32. FUDIM M, Salah HM, Sathananthan J, Bernier M, et al
    Lymphatic Dysregulation in Patients With Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2021;78:66-76.
    PubMed         Abstract available


    J Card Fail

  33. VADUGANATHAN M, Li D, van Meijgaard J, Warraich HJ, et al
    US Nationwide Prescription Fill Patterns of Evidence-Based Medical Therapies for Heart Failure During the COVID-19 Pandemic.
    J Card Fail. 2021 Jun 28. pii: S1071-9164(21)00260.
    PubMed         Abstract available

  34. MENTZ RJ, Mulder H, Mosterd A, Sweitzer NK, et al
    Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial: VICTORIA Outcomes Model.
    J Card Fail. 2021 May 26. pii: S1071-9164(21)00206.
    PubMed         Abstract available


    J Cardiovasc Pharmacol

  35. ADIE SK, Ketcham SW, Abdul-Aziz AA, Thomas MP, et al
    Characteristics of heart failure patients with or without hypotension when transitioning from nitroprusside to sacubitril-valsartan.
    J Cardiovasc Pharmacol. 2021 Jun 21. pii: 00005344-900000000-98191.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  36. THOMPSON MP, Likosky DS
    Commentary: Can and should the National Inpatient Sample be used to evaluate trends in ventricular assist device use and outcomes?
    J Thorac Cardiovasc Surg. 2021;161:2093-2094.
    PubMed        

  37. ALSOUFI B
    Commentary: Mitochondrial transplantation for myocardial failure, marvel remedy or wishful thinking?
    J Thorac Cardiovasc Surg. 2021;162:e125-e126.
    PubMed        


    PLoS Med

  38. CHUA W, Law JP, Cardoso VR, Purmah Y, et al
    Quantification of fibroblast growth factor 23 and N-terminal pro-B-type natriuretic peptide to identify patients with atrial fibrillation using a high-throughput platform: A validation study.
    PLoS Med. 2021;18:e1003405.
    PubMed         Abstract available


    PLoS One

  39. KATO M, Mori Y, Watanabe D, Onoda H, et al
    Relationship between average daily rehabilitation time and decline in instrumental activity of daily living among older patients with heart failure: A preliminary analysis of a multicenter cohort study, SURUGA-CARE.
    PLoS One. 2021;16:e0254128.
    PubMed         Abstract available

  40. KAWASE Y, Kato T, Morimoto T, Hata R, et al
    Admission systolic blood pressure as a prognostic predictor of acute decompensated heart failure: A report from the KCHF registry.
    PLoS One. 2021;16:e0253999.
    PubMed         Abstract available

  41. TANIGUCHI C, Seto N, Shimizu Y
    Outpatient nursing support for self-monitoring in patients with chronic heart failure.
    PLoS One. 2021;16:e0254019.
    PubMed         Abstract available

  42. HAMO CE, Abdelmoneim SS, Han SY, Chandy E, et al
    OUTpatient intravenous LASix Trial in reducing hospitalization for acute decompensated heart failure (OUTLAST).
    PLoS One. 2021;16:e0253014.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: